Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,594 | Dovepress* | 5,369+ | 183 | 5,552 | |
PubMed Central* | 225 | 104 | 329 | ||
Totals | 5,594 | 287 | 5,881 | ||
*Since 13 November 2021 |
View citations on PubMed and Google Scholar